Furukawa Miki, Ohkawara Hiroshi, Ogawa Kazuei, Ikeda Kazuhiko, Ueda Koki, Shichishima-Nakamura Akiko, Ito Emi, Imai Jun-Ichi, Yanagisawa Yuka, Honma Reiko, Watanabe Shinya, Waguri Satoshi, Ikezoe Takayuki, Takeishi Yasuchika
From the Departments of Hematology.
From the Departments of Hematology,
J Biol Chem. 2017 Mar 10;292(10):4280-4292. doi: 10.1074/jbc.M116.733030. Epub 2017 Jan 31.
The pathogenesis of multiple myeloma (MM) has not yet been fully elucidated. Our microarray analysis and immunohistochemistry revealed significant up-regulation of growth arrest-specific gene 6 (Gas6), a vitamin K-dependent protein with a structural homology with protein S, in bone marrow (BM) cells of MM patients. ELISA showed that the serum levels of soluble Gas6 were significantly increased in the MM patients when compared with healthy controls. Gas6 was overexpressed in the human CD138-positive MM cell line RPMI-8226. Exogenous Gas6 suppressed apoptosis induced by serum deprivation and enhanced cell proliferation of the MM cells. The conditional medium from the human BM stromal cell line HS-5 induced cell proliferation and anti-apoptosis of the MM cells with extracellular signal-regulated kinase, Akt, and nuclear factor-κB phosphorylation, which were reversed by the neutralizing antibody to Gas6 or IL-6. The TAM family receptor Mer, which has been identified as a Gas6 receptor, was overexpressed in BM cells of MM patients. The knockdown of Mer by siRNA inhibited cell proliferation, anti-apoptosis, and up-regulation of intercellular cell adhesion molecule-1 (ICAM-1) in MM cells stimulated by an HS-5 cell-conditioned medium. Furthermore, the Gas6-neutralizing antibody reduced the up-regulation of IL-6 and ICAM-1 induced by a HS-5 cell-conditioned medium in MM cells. The present study provides new evidence that autocrine and paracrine stimulation of Gas6 in concert with IL-6 contributes to the pathogenesis of MM, suggesting that Gas6-Mer-related signaling pathways may be a promising novel target for treating MM.
多发性骨髓瘤(MM)的发病机制尚未完全阐明。我们的微阵列分析和免疫组织化学显示,在MM患者的骨髓(BM)细胞中,生长停滞特异性基因6(Gas6)显著上调,Gas6是一种维生素K依赖性蛋白,与蛋白S具有结构同源性。酶联免疫吸附测定(ELISA)表明,与健康对照相比,MM患者血清中可溶性Gas6水平显著升高。Gas6在人CD138阳性MM细胞系RPMI-8226中过表达。外源性Gas6抑制血清剥夺诱导的细胞凋亡,并增强MM细胞的增殖。人骨髓基质细胞系HS-5的条件培养基通过细胞外信号调节激酶、Akt和核因子κB磷酸化诱导MM细胞增殖和抗凋亡,而Gas6或IL-6的中和抗体可逆转这种作用。已被鉴定为Gas6受体的TAM家族受体Mer在MM患者的BM细胞中过表达。通过小干扰RNA(siRNA)敲低Mer可抑制HS-5细胞条件培养基刺激的MM细胞的增殖、抗凋亡以及细胞间黏附分子1(ICAM-1)的上调。此外,Gas6中和抗体可降低HS-5细胞条件培养基诱导的MM细胞中IL-6和ICAM-1的上调。本研究提供了新的证据,表明Gas6与IL-6协同的自分泌和旁分泌刺激参与了MM的发病机制,提示Gas6-Mer相关信号通路可能是治疗MM的一个有前景的新靶点。